Co-amplification of CCNE1 and AKT2 as a prognostic biomarker for treatment response and potential target in patients with high-grade serous ovarian cancer
Research Project | 01.01.2025 - 31.05.2026
|
01.01.2025
- 31.05.2026
Funding
Co-amplification of CCNE1 and AKT2 as a prognostic biomarker for treatment response and potential target in patients with high-grade serous ovarian cancer
Forschungsfonds (Excellent Junior Researcher) (GrantsTool), 01.2025-05.2026 (17)
PI : Zwimpfer, Tibor.
Members (1)
